tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Gossamer Bio’s Seralutinib: Promising Advancements in PAH Treatment Reinforce Buy Rating
PremiumRatingsGossamer Bio’s Seralutinib: Promising Advancements in PAH Treatment Reinforce Buy Rating
1M ago
Cantor says has reinforced conviction on Gossamer Bio ahead of data readout
Premium
The Fly
Cantor says has reinforced conviction on Gossamer Bio ahead of data readout
1M ago
Gossamer Bio upgraded to Buy from Neutral at UBS
Premium
The Fly
Gossamer Bio upgraded to Buy from Neutral at UBS
1M ago
Gossamer Bio initiated with an Outperform at Scotiabank
PremiumThe FlyGossamer Bio initiated with an Outperform at Scotiabank
3M ago
Gossamer Bio Approves 2019 Incentive Award Plan
Premium
Company Announcements
Gossamer Bio Approves 2019 Incentive Award Plan
4M ago
Optimistic Buy Rating for Gossamer Bio Amid Strong Phase 3 PROSERA Study Progress and Competitive Landscape
Premium
Ratings
Optimistic Buy Rating for Gossamer Bio Amid Strong Phase 3 PROSERA Study Progress and Competitive Landscape
4M ago
Gossamer Bio’s Earnings Call: Mixed Sentiments and Strategic Moves
PremiumCompany AnnouncementsGossamer Bio’s Earnings Call: Mixed Sentiments and Strategic Moves
5M ago
Gossamer Bio Reports Q1 2025 Results and Study Updates
Premium
Company Announcements
Gossamer Bio Reports Q1 2025 Results and Study Updates
5M ago
Gossamer Bio reports Q1 EPS (16c), consensus (19c)
Premium
The Fly
Gossamer Bio reports Q1 EPS (16c), consensus (19c)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100